Home > Services > Clinical Research Studies > Clinical Trials Details
<< Back to Results
This phase II trial is studying fludeoxyglucose F 18-PET/CT imaging to see how well it works in assessing response to combination chemotherapy and allow doctors to plan better additional further treatment in treating patients with stage III or stage IV Hodgkin lymphoma.
Essentia Health Brainerd, Essentia Health Duluth, Essentia Health Fargo
For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.